| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/02/2013 | CA2519705C Antifungal nail coat and method of use |
| 07/02/2013 | CA2504582C Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
| 07/02/2013 | CA2502025C Pharmaceutical compositions having a modified vehicle |
| 07/02/2013 | CA2445729C Use of metals to treat mucosal membranes |
| 06/27/2013 | WO2013096811A2 Transmucosal drug delivery devices for use in chronic pain relief |
| 06/27/2013 | WO2013096792A1 Method for repairing or replacing damaged tissue |
| 06/27/2013 | WO2013096689A1 Anti allergen composition and spray formulation comprising the same |
| 06/27/2013 | WO2013096626A1 Implantable intraocular drug delivery apparatus, system and method |
| 06/27/2013 | WO2013096596A1 Sustained drug release and improved product stability using non-covalent particle coating methods |
| 06/27/2013 | WO2013096560A1 Excipient-free aerosol formulation |
| 06/27/2013 | WO2013096405A1 Chewing gum products containing [(2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester |
| 06/27/2013 | WO2013096393A1 Aqueous dispersions and precursors thereof |
| 06/27/2013 | WO2013096349A1 Transparent microemulsions with a film-forming styling polymer and methods for making the same |
| 06/27/2013 | WO2013096337A1 Composition for enzymatic debridement |
| 06/27/2013 | WO2013096239A1 Co-processing method and formulation for hiv attachment inhibitor prodrug compound and excipients |
| 06/27/2013 | WO2013096176A1 Hemostatic materials and devices with galvanic particulates |
| 06/27/2013 | WO2013096173A1 Contact lenses containing carotenoid and method for making same |
| 06/27/2013 | WO2013096027A1 Adhesive patch assembly with overlay liner and system and method for making same |
| 06/27/2013 | WO2013096026A1 Transdermal adhesive patch assembly with removable microneedle array and method of using same |
| 06/27/2013 | WO2013095320A1 Flurbiprofen formulations |
| 06/27/2013 | WO2013095319A2 Formulations of flurbiprofen and diacerein |
| 06/27/2013 | WO2013095318A2 Orally-disintegrating formulations of flurbiprofen |
| 06/27/2013 | WO2013095317A2 Pharmaceutical formulations of flurbiprofen and glucosamin |
| 06/27/2013 | WO2013095315A1 Formulations comprising dexketoprofen (particle size 300-2500 micrometer) |
| 06/27/2013 | WO2013095314A1 Pharmaceutical formulations comprising risperidone |
| 06/27/2013 | WO2013095313A1 Pharmaceutical formulations comprising cefdinir |
| 06/27/2013 | WO2013095312A1 Formulations comprising quetiapine fumarate |
| 06/27/2013 | WO2013095166A1 Antibiotic formulations |
| 06/27/2013 | WO2013095111A1 Simethicone formulation |
| 06/27/2013 | WO2013095042A2 Granule containing imatinib mesylate, immediate release oral tablet composition containing same, and preparation method thereof |
| 06/27/2013 | WO2013094955A1 Composition comprising biodegradable polymer fine particles having improved dispersibility and method for preparing same |
| 06/27/2013 | WO2013094722A1 Cancer cell-inhibiting ceramics and method for producing cancer cell-inhibiting ceramics, method for treating bone neoplasm, and use of β tricalcium phosphate porous granules having grain size of 1 to 10 μm |
| 06/27/2013 | WO2013094683A1 Composition for skin containing silicone base |
| 06/27/2013 | WO2013094077A1 Cosmetic bio-cellulose sheet for lips |
| 06/27/2013 | WO2013093934A1 Process for preparation of decitabine injection |
| 06/27/2013 | WO2013093912A1 Compositions and methods for improving stability and extending shelf life of flavoring agents |
| 06/27/2013 | WO2013093891A1 Liposomal chlorite or chlorate compositions |
| 06/27/2013 | WO2013093659A1 Natural, multiple release and re-use compositions |
| 06/27/2013 | WO2013093648A2 Method of producing lipid nanoparticles for drug delivery |
| 06/27/2013 | WO2013093630A2 Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof |
| 06/27/2013 | WO2013093525A1 Reconstitution method for high concentration dry protein formulations |
| 06/27/2013 | WO2013093524A2 Method for preparing amorphous precipitated protein particles |
| 06/27/2013 | WO2013093456A1 Drug delivery technology |
| 06/27/2013 | WO2013093216A1 Topical film-forming composition, and use thereof for treating or preventing onychophagia |
| 06/27/2013 | WO2013093164A1 Tranexamic acid gel |
| 06/27/2013 | WO2013092860A2 Hyaluronic acid and its use for treating venous insufficiency and varicose veins |
| 06/27/2013 | WO2013092673A2 New combination |
| 06/27/2013 | WO2013092589A1 Multiple unit pellet tablet formulation comprising an opioid |
| 06/27/2013 | WO2013092558A1 Preparations containing amorphous emodepside |
| 06/27/2013 | WO2013092497A1 Immediate release multi unit pellet system |
| 06/27/2013 | WO2013092345A1 An inhaler comprising a tiotropium-containing-composition |
| 06/27/2013 | WO2013092284A1 Dialysis precursor composition |
| 06/27/2013 | WO2013092283A1 Dialysis precursor composition |
| 06/27/2013 | WO2013092237A1 An inhalable medicament comprising tiotropium |
| 06/27/2013 | WO2013091901A1 Detection system for detecting magnetic objects in the human organism |
| 06/27/2013 | WO2013091704A1 Pharmaceutical composition comprising fingolimod |
| 06/27/2013 | WO2013091631A1 Method of releasing nicotine from chewing gum |
| 06/27/2013 | WO2013091595A1 Pharmaceutical formulation of prasugrel hydrobromide |
| 06/27/2013 | WO2013091283A1 Pharmaceutical compositions of triptorelin microspheres |
| 06/27/2013 | WO2013091056A1 Pharmaceutical compositions comprising arrabidaea chica extract in controlled release systems, production process and use thereof |
| 06/27/2013 | WO2013091053A1 Polymer composition containing natural bioactive principles for use in pharmaceutical and cosmetic formulations |
| 06/27/2013 | WO2013091006A1 Process for dry powder blending |
| 06/27/2013 | WO2013062442A3 Composition for the treatment of multiple sclerosis (variants) |
| 06/27/2013 | WO2013056108A3 Solid dispersions of a erb2 (her2) inhibitor |
| 06/27/2013 | WO2013039713A3 Positive pressure medical dressings with valve and kits containing same |
| 06/27/2013 | WO2013025239A3 Mesh enclosed tissue constructs |
| 06/27/2013 | WO2013024474A8 Polymorphs of preladenant |
| 06/27/2013 | WO2013021346A3 A novel method for peroral delivery of insulin and its analogues for therapeutic usage |
| 06/27/2013 | WO2012116225A9 Muc1 based glycolipopeptide vaccine with adjuvant |
| 06/27/2013 | WO2012075455A3 Rapidly dispersing granules, orally disintegrating tablets and methods |
| 06/27/2013 | WO2012065680A3 Dihydroxyfumaric acid derivatives, and use thereof for bleaching skin |
| 06/27/2013 | WO2011038104A3 Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
| 06/27/2013 | US20130165876 Patch preparation |
| 06/27/2013 | US20130165526 Topical treatment with dapsone in g6pd-deficient patients |
| 06/27/2013 | US20130165518 Ibuprofen and narcotic analgesic compositions |
| 06/27/2013 | US20130165503 Method for Treating Ocular Neovascularization |
| 06/27/2013 | US20130165481 Small-volume oral transmucosal dosage forms |
| 06/27/2013 | US20130165403 Process for Manufacturing Partially Cross-Linked Alginate Solution |
| 06/27/2013 | US20130165377 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 06/27/2013 | US20130165373 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 06/27/2013 | US20130165372 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 06/27/2013 | US20130164843 Method and medicament for inhibiting the expression of a given gene |
| 06/27/2013 | US20130164815 Process for the production of a reversibly inactive acidified plasmin composition |
| 06/27/2013 | US20130164495 Patch backing for water-based pasty preparation |
| 06/27/2013 | US20130164400 Single use system for sterilely producing lipid-nucleic acid particles |
| 06/27/2013 | US20130164389 Calcium Carbonate Granulation |
| 06/27/2013 | US20130164382 Ejaculum of animals as medicinal material and uses thereof in medicaments for treatment of diseases such as tumors, depression, etc |
| 06/27/2013 | US20130164381 Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation |
| 06/27/2013 | US20130164380 Compositions and methods for treating inflammatory conditions |
| 06/27/2013 | US20130164377 Shell-and-core dosage form approaching zero-order drug release |
| 06/27/2013 | US20130164374 Reduction in bacterial colonization by administering bacteriophage compositions |
| 06/27/2013 | US20130164373 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 06/27/2013 | US20130164372 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 06/27/2013 | US20130164370 Novel formulation of pegylated-liposome encapsulated glycopeptide antibiotics |
| 06/27/2013 | US20130164369 Telodendrimer nanodiscs without apolipoprotein |
| 06/27/2013 | US20130164366 Method and medicament for inhibiting the expression of a given gene |
| 06/27/2013 | US20130164364 Liposome targeting compounds and related uses |
| 06/27/2013 | US20130164360 Hemostatic Materials and Devices with Galvanic Particulates |
| 06/27/2013 | US20130164351 Methods of treating bacterial infections through pulmonary delivery of fusidic acid |
| 06/27/2013 | US20130164350 Sustained release formulation of nalbuphine |